EIGER BIOPHARMACEUTICALS
Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.
EIGER BIOPHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.eigerbio.com
Total Employee:
11+
Status:
Active
Contact:
(650)272-6138
Email Addresses:
[email protected]
Total Funding:
156.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2015-11-18 | Celladon | Celladon acquired by Eiger BioPharmaceuticals | N/A |
Investors List
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Equity - Eiger BioPharmaceuticals
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Debt - Eiger BioPharmaceuticals
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Eiger BioPharmaceuticals
InterWest Partners
InterWest Partners investment in Debt Financing - Eiger BioPharmaceuticals
InterWest Partners
InterWest Partners investment in Series A - Eiger BioPharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Eiger BioPharmaceuticals
InterWest Partners
InterWest Partners investment in Series A - Eiger BioPharmaceuticals
Vivo Capital
Vivo Capital investment in Series A - Eiger BioPharmaceuticals
RA Capital Management
RA Capital Management investment in Seed Round - Eiger BioPharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.eigerbio.com Semrush global rank: 2.28 M Semrush visits lastest month: 8.31 K
- Host name: 172.67.75.113
- IP address: 172.67.75.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago